Objective: Understanding which population groups intentionally poison themselves by overdose and which substances are used are key to developing prevention efforts for such injuries. This paper uses Ministry of Health (MOH) data to explore the demographic characteristics of those who intentionally self-poison and the substances used, identifies limitations of existing data collections and makes recommendations for the future. Methods: MOH mortality data from 2000 to 2012, and public hospital presentation data from 2000-2014 of cases of intentional self-poisoning (ISP), and poisoning of undetermined intent (UDP), were examined. Results: Men were more at risk of fatal intentional poisonings, while young women and people from deprived areas were predominant in hospital presentations for ISP and UDP. While ICD-10 categories were available, there was limited information in the majority of MOH data about specific substances used in the poisonings.
N ew Zealand (NZ) public hospital emergency departments (EDs) see at least 2,500 presentations for intentional self-poisoning (ISP) every year. ISP is the intentional ingestion of more than the prescribed or advised amount of any drug, recreational drug, non-ingestible substance, or excess alcohol, regardless of whether there is evidence of intent to die of the poisoning or not. 1 ISP is involved in 65% of all public hospital presentations due to poisoning, while 29% are unintentional, and 6% are of undetermined intent. 2 ISP presentations to public hospitals use significant healthcare resources and previous self-harm, including ISP, is a significant risk factor for subsequent suicide. 3 As many as 77% of intentional self-harm (ISH) incidents in NZ may involve ISP. 1 Interventions to prevent suicide and self-harm should include people who have intentionally self-poisoned as a target group. Demonstrating efficacy in suicide prevention is very difficult, and one of the only methods shown to be effective is preventing access to means of suicide. 4 To better understand the problem of ISP and how to address preventing it, largescale, accurate, descriptive data are needed. Suicides are always investigated by a Coroner in NZ, and the Ministry of Health (MOH) collects data on all such deaths, 5 and on public hospital presentations. 6 These data could potentially be used to plan local or nationwide interventions to prevent or at least reduce the prevalence and incidence of ISP.
The NZ MOH collects public and private hospital discharge event data into the National Minimum Dataset (NMDS). 6 The NMDS is intended for policy formation, performance monitoring, funding decisions, research and review of health services in NZ. 7 In this dataset, ISP is categorised according to groups of substances used in the poisoning, by World Health Organization (WHO) International Classification of Diseases (ICD-10) codes X60-X69. 8 Poisoning of undetermined intent (UDP) refers to similar poisonings in cases where intent could not be determined but could not be ruled unintentional, and can be described by ICD-10 codes Y10-Y19. 8 Some example substances of these groups are presented in Table 1 . A substantial number of UDP may in fact be ISP where the patient has not wished to disclose intent to the clinician, 9 and therefore it can be argued that UDP should also be investigated.
This project aimed firstly to investigate how MOH mortality and NMDS data could be used to understand ISP. Cases of undetermined intent were included in an effort to more comprehensibly understand the burden of potential intentional poisonings in NZ.
The most recent available periods of data were chosen and people of all ages were investigated, in an effort to expand on previous research done in NZ. 2 Secondly, in the context of reducing inappropriate access to substances frequently occurring in ISP events, we sought to investigate the limitations of the current data and make recommendations about what other information could be useful to be further included in these national data collections.
Methods
The Human Research Ethics Committee of the University of Otago, NZ approved the study protocol. MOH data on deaths due to ICD-10 classification codes X60-X69 (ISP) and Y10-Y19 (UDP) for the years 2000-2012 (year of death; mortality data), and NMDS public hospital presentations of at least 24 hours duration due to the same ICD-10 codes for the years 2000-2014 (admission year; hospitalisation data) were obtained from the MOH in October 2015. 10 Deaths and hospital presentations due to undetermined intent were included because some of these may in fact be the result of ISP. Populationdescriptive variables systematically collected and available in the two datasets were analysed in the study.
Demographic descriptors
These data were analysed in SPSS (IBM, statistics version 22 
Presentation descriptors
The cause of death/presentation and hospital presentation parameters such as length of stay and time until next presentation due to ISP or UDP were investigated. Any two hospital presentations due to ISP or UDP during the same 24-hour period were treated as one presentation when analysing time until next presentation. To avoid overestimating prevalence rates of ICD-10 codes, a case having multiple copies of the same code was treated as having the code once. The MOH hospitalisation data contained encrypted National Health Index (NHI, a personal identifier) numbers to identify presentations as events happening to the same individual patients. Dataset content was investigated using individual substances most 
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frequently found in overdoses presenting at Wellington Regional Hospital as descriptors of specific substance data availability.
12

Population particulars and rates
A higher level of ethnicity coding with four groups (Māori, Pasifika, Asian, 'Other' (including NZ European) and also 'Unknown' in hospital presentations) was used to avoid negatively labelling or accidentally identifying members of very small ethnic groups, but also because this has been shown to be more accurate for Pasifika people's NHI data. 13 The 
Results
Deaths from intentional self-poisoning and poisoning of undetermined intent
A clear majority (n = 1,751; 93%) of the 1,881 ISP and UDP poisoning deaths from 2000 to 2012 were intentionally self-inflicted, while 130 (7%) were of undetermined intent.
Demographic descriptors
Two-thirds (n = 1,258; 67%) of those who died of ISP or UDP were men, while 623 (33%) were women. Of all the deaths, 155 people (8%) were Māori, 25 (1%) were Pasifika, 47 (2%) were Asian, and 1,654 (88%) of 'Other' ethnicity (including NZ European). Those who died of ISP were fairly young, with 50% of Māori, 68% of Pasifika, 40% of Asian, and 27% of 'Other' ethnicity decedents aged younger than 35. There were only three deaths in those aged 0-14 (one male and two females). The rates of ISP and UDP deaths in 2000-2012 are presented in Table 1 .
Causes of death
A total of 1,831 deaths (97%) were certified by a Coroner, 43 had a Coroner's interim report, seven had been certified by a doctor, and a post mortem examination was registered in the data for 1,783 cases (95%). The most common cause of death for men was by 'other gases and vapours' (X67 or Y17), including for example carbon monoxide and helium, with 841 men (67%) dying through these methods. Table 1 . There were no details available in the MOH dataset about which specific substances within the ICD-10 group coded were used in the poisonings in the majority of cases, except in 603 cases (32%) where some free text field details were available. The results for all the toxicants suggested by the ICD-10 coding, however, were not listed in all of these 603 cases, and therefore from the mortality data alone it was impossible to ascertain whether there were other substances besides the ones listed involved or not.
Public hospital presentations due to intentional self-poisoning and poisoning of undetermined intent
In the 15-year period investigated (2000-2014), there were 43,777 public hospital presentations by 28,648 people for ISP and UDP (short stays excluded).
Demographic descriptors
A third (n=10,204; 36%) of the people and 14,050 (32%) of the presentations were men, while 18,444 (64%) of the people and 29,727 (68%) of the presentations were women. About a third (n=14,576; 33%) of the presentations were of people aged younger than 25. A total of 303 male and 1,543 female presentations were by people aged under 15, and of these a total of 1,737 presentations (94%) were by people aged 10-14. Prioritised ethnicity information was missing in 503 (1%) presentations, and NZDep2006 index was missing in 258 (0.6%). The age-standardised rates of ISP and UDP hospital presentations by sex, prioritised ethnicity, and NZDep2006 index, and crude rates by age group, are presented in Table 1 .
Cause of presentation
Most presentations (n = 38,986; 89%) involved at least one ISP code (X60-X69), while 4,838 (11%) involved at least one UDP code (Y10-Y19), and 47 (0.1%) involved both ISP and UDP codes. Most presentations (n = 38,939; 89%) had no UDP codes, while 4,791 (11%) had no ISP codes. Of the presentations by people aged 0-14, 1,549 (84%) were due to ISP and 297 (16%) were due to UDP. Half the presentations of all ages (n = 22,536; 52%) had one ISP or UDP code, 13,371 (31%) had two, 5,454 (13%) had three, 1,789 (4%) had four, and 627 (1%) had five codes. Age-standardised rates of presentations by sex and by cause are presented in Table 1 . The same ISP or UDP code appeared more than once within 796 presentations (2%), and when calculating ICD-10 code rates, any given ISP or UDP code was counted only once within the same presentation. There appeared to be an increase in 'narcotics' (X62+Y12; for example opioids) and 'alcohol' (X65+Y15) poisonings over time, whereas poisonings by 'other gases and vapours' (X67+Y17) appeared to decrease (Figure 1 ).
Substance groups and specific substances
A total of 1,240 presentations (2.8%) included diagnosis codes that did not give details about the specific substances: T50.9 ('Other and unspecified drugs, medicaments and biological substances'), T65.8 ('Toxic effect of other specified substances'; there is no free text field to specify these in this dataset), and T65.9 ('Toxic effect of unspecified substance'). A total of 14,786 presentations (34%) had at least one diagnostic code of the 'unspecified substance' within the T-code group. This was inclusive of across a wide range of agents from 'Nonopioid analgesic, antipyretic and antirheumatic, unspecified' (T39.9) through to 'Toxic effect of contact with unspecified venomous animal' (T63.9). Thus although a class of drugs or other agents is provided, the specific agent is not.
The most frequent T-codes per X and Y group were determined. The agents most frequently encountered in overdose in Wellington Regional Hospital were used as indicators of data availability, and include paracetamol, zopiclone, quetiapine, codeine, ibuprofen, citalopram, clonazepam, fluoxetine, and diazepam.
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Agent-specific information is likely to be reliable in the following ISP subcodes, where the frequency of unspecified agents was low (<15%). 'Non-opioid analgesics' (X60+Y10) only had 1% unspecified coding (T39.9), while 82% of these presentations indicated paracetamol (T39.1) and 27% indicated nonsteroidal anti-inflammatory drugs (NSAIDs) other than salicylates (T39.0). Ibuprofen alone could not be identified. 'Narcotics' (X62+Y12) had 3% unspecified codes from within the class (T40.6; T40.9), and 88% indicated opioids (T40.0-T40.4). Codeine alone could not be identified. 'Other drugs acting on the autonomic nervous system' (X63+Y13) had 15%, and 'other and unspecified drugs, medicaments and biological substances'
© 2017 The Authors (X64+Y14) had 14% presentations where there was an unspecified code from within the class. 'Alcohol' (X65+Y15) presentations had 5% unspecified alcohols (T51.9), and 92% indicated ethanol (T51.0). 'Organic solvents and halogenated hydrocarbons and their vapours' (X66+Y16) presentations had 9% unspecified codes (T52.9, T53.9), while 'other gases and vapours' (X67+Y17) had 1% unspecified codes (T59.9), and 85% had a code for carbon monoxide (T58). 'Pesticides' (X68+Y18) presentations had 10% unspecified pesticides (T60.9).
In contrast, 'antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified' (X61+Y11) had a 47% non-specified rate (T42.7; T43.2; T43.5; T43.9), making it very difficult to advise on which specific agents are causing harm. Of presentations classed X61+Y11, 17% had a code indicating 'tricyclic and tetracyclic antidepressants' (T43.0), 31% indicated 'other and unspecified antidepressants' (T43.2) which includes citalopram and fluoxetine, 23% indicated 'other and unspecified antipsychotics and neuroleptics' (T43.5) which includes quetiapine, 32% indicated benzodiazepines (T42.4) which includes clonazepam and diazepam, and 31% indicated 'Other antiepileptic and sedativehypnotic drugs' (T42.6) which includes zopiclone. None of these X61+Y11 class 'indicator substances' could be identified separately. 'Other and unspecified chemicals and noxious substances' (X69+Y19) comprised 34% of unspecified codes (T54.9, T59.9, T57.9, T61.9, T62.9, T63.9, T65.8, T65.9).
Presentation descriptors
Three-quarters of people (n=21,703; 76%) presented only once during the 15-year study period, while 6,945 people (24%) presented more than once. There were 603 presentations on the same day as another presentation by the same person (by encrypted NHI), and these were excluded and investigated. In 97 of these excluded cases (16%) the data available suggested that it may have been another, new presentation on the same day, while for 431 cases (72%) they indicated patient transfers for the same presentation, and for 75 cases (12%) they were unclear. The number of times a person presented, the length of stay in hospital, and the number of days between two consecutive ISP or UDP presentations (where applicable), are described in Table 2 , and excluded same day presentations by the same person. Total hours spent in an intensive care unit was available for 3,221 presentations (7%), and the mean hours spent was 39.6 (95%CI 38.1-41.2).
Conclusions
The ISP and UDP death rate for men was higher but the hospital presentation rate was lower than for women. These male and female prevalence rates are similar to previous studies' incidence rates, 2 taking into account that we included poisonings of undetermined intent, and people younger than 25. We chose to look at prevalence rather than incidence, as repeat presentations would be of as much concern, if not more, than first presentations. Since the majority of people presented to a hospital only once during the time-period investigated, the prevalence rates approach incidence rates in this population.
The highest ISP and UDP hospital presentation rate for men was for Māori men, while the highest rates for women were those for Māori and 'Other' (including NZ European) ethnicity women. Those aged 35-44 had the highest ISP and UDP death rates, while those aged 15-24 had the highest hospital presentation rates. The hospital presentation rates for women were mostly two-fold compared to men by age groups; however, in the 65+ age group the rates were equal, and in the 0-14 age group women's was 5.3-fold that of men's. NZDep2006 indexing by domicile did not change ISP and UDP death rates significantly, but for hospital presentation rates, the rates in the two most deprived quintiles (7-8, 9-10) were double those in the least deprived quintile (1-2). These findings are in line with recent rates of suicide and self-harm in NZ. 15 There appeared to be a trend for Māori, Pasifika, and Asian people to present to hospitals due to ISP fewer times than people of 'Other' (including NZ European) ethnicity. Length of stay in hospital or days between two subsequent presentations did not differ markedly by ethnicity, though Māori appeared to have a shorter mean stay at hospital and longer time until a subsequent presentation than people of 'Other' ethnicity.
'Other gases and vapours' (X67+Y17) was the most common ISP or UDP cause of death for men, with a rate 4.6 times as high as for the second most common method, 'antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified' (X61+Y11). While the MOH mortality data alone do not allow identification of specific substances, the gas in question in deaths due to 'X67' is often carbon monoxide in NZ, 2, 16 as was the case also for hospital presentations due to X67 and Y17 in our study.
Specific toxicant data were missing or limited in cases of ISP and UDP deaths, though it is likely that toxicological analysis was done during autopsies for Coroner's rulings. Substance information was also somewhat limited in the hospital presentation data due to ICD-10 group structures (in the X, Y, and T-codes), though many cases would be expected to have some toxicant details recorded in hospital data systems. While a third of presentations had at least one unspecified substance involved, the high prevalence of paracetamol, benzodiazepines, opioids, and ethanol was observed. As noted with the specific example substances, a further limitation of interpretations of the data stemming from ICD-10 group structure is that for example many modern antidepressants, including selective serotonin reuptake inhibitors (SSRIs) citalopram and fluoxetine, fall under 'other and unspecified antidepressants' (T43.2). Using this ICD-10 group prevents analysis by these substance groups separately, and of trends over time as new substances are introduced. The observed apparent increase over time in ISP through 'narcotics' (X62+Y12) may reflect the general increase in opioid consumption in many 'Western' countries including NZ over time, 17 but the datasets used in this study
do not indicate which opioid may be most problematic. Codeine was the most prevalent opioid in Wellington Regional Hospital data.
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Study limitations
Suicide mortality data are generally considered reliable, as they involve a Coroner's investigation, with often a post mortem examination, toxicology testing, and a pathologist statement involved in determining cause of death. 5 A limitation of our hospital presentation analysis is that encrypted NHI numbers used to identify persons presenting may have errors and we cannot exclude the possibility that this de-identified method of counting numbers of people and identifying cases that are repeat presentations may lead to over or underestimations. Excluding private hospital presentations may lead to underestimation of rates, but due to data collection differences they needed to be excluded. 1 Other known data issues with NMDS include inaccuracies in coding. 1, 18, 19 Including poisonings of undetermined intent (Y10-Y19) resulted in 7% more deaths and 11% more hospital presentations, and the justification of these inclusions could not be investigated further, as details about the events were not available. As these cases had not been ruled unintentional, and as poisoning as a method is perhaps less indicative of intent than other forms of self-harm such as hanging, 20 we feel this inclusion was warranted. Including hospital presentation cases of undetermined intent in the very young age groups, especially those younger than ten, may be questioned further, as poisonings may be coded as UDP if for example assault rather than an unintentional event is suspected.
Determining a set 'cut-off' age limit for a child understanding intentional self-harm as such is difficult, and the numbers of hospital presentations by people younger than ten were low in the study sample. The possible confounding effect of including UDP cases on child/youth rates as descriptors of prevalence of ISP is limited, yet we cannot exclude the possibility that a small number of cases not related to intentional self-poisoning were included in our study sample. A strength of this study is the additional information on substance groups offered by ICD-10 T-codes used beside the X and Y-codes.
Implications for public health
Implications of data limitations
There were no uniformly formatted details available about specific substances in MOH mortality and hospitalisation data beyond the ICD-10 groups, which naturally limits interpretations that can be made from them.
Obtaining toxicology results separately, as Gallagher and colleagues 16 have admirably done in their analysis of poisoning deaths requires significant time, and while we acknowledge significant time input would also be needed to incorporate this toxicology data into the MOH material, including them would increase the usefulness of these data significantly. Collecting specific substance details in hospitalisation data would be of importance, as a significant proportion of ISP does not lead to death and Coronial investigation, but hospital treatment and/ or observation only. This information should be collected at the point of contact with the patient. As this information may be recorded in the patient file to facilitate treatment decisions, extracting it for MOH data, in addition to the ICD-10 codes, would be justified. For example developing a pop-up window for such a purpose when a poisoning case is entered on a hospital computer system such as EDIS, as done routinely in Wellington Regional Hospital ED, could be a way of collecting these data. EDIS has also been successfully used to extract specific ISP data in the United Kingdom. 21 Improving substance information collection and linking the mortality and NMDS datasets could perhaps be used to develop automatic or other software 'flags' that would recognise for example increasingly lethal drug combinations in big data such as NMDS and alert the treating clinician to (re)evaluate patient ISP risk.
The high prevalence of 'antiepileptic, sedative-hypnotic, antiparkinsonism and psychotropic drugs, not elsewhere classified' (X61), especially in female ISP hospital presentations raises concerns; however, the data here do not tell us which specific drugs may be the most problematic. This study indicated that benzodiazepines and tricyclic and tetracyclic antidepressants were significant substance groups. Recent data from Wellington Hospital ED indicate zopiclone, quetiapine, citalopram, clonazepam, fluoxetine and diazepam from the X61 group, and paracetamol from the ICD-10 group X60 as the most commonly misused or overdosed agents. 12 Expanding such poisoning monitoring and analysis to all NZ hospitals would give valuable information for designing prevention measures. As there have been differences in coding practices between District Health Boards (DHBs) that have affected national data quality, such as recording short stays, 10 arranging uniform nationwide toxicant data collection may be challenging. We support the recommendation to establish a national lead agency to address these concerns. 25 If therapeutic alliances between patients at risk of intentional overdose and their caregivers could be facilitated through, for example, fully government-subsidised weekly dispensing of medications in amounts that are tailored and considered safe for the patient in question, the costs from these practices could perhaps be off-set by reductions in some of the significant costs caused by self-harm through poisoning. This, however, requires further study.
In summary, we suggest that it would be useful for suicide and self-harm prevention planning activities to: 1) collect substance level data of intentional poisonings as often as possible; 2) monitor trends in local prevalence of problematic substances appearing in cases of intentional selfpoisoning; 3) verify harmonised short-stay hospital presentation data collection across NZ, and increase reporting of it to broaden our understanding of intentional selfpoisoning by including also those presenting for only a short stay at the hospital; and 4) establish a national lead agency to monitor and address these poisonings and assist localised efforts in managing intentional selfpoisoning.
